Saxenda, like Ozempic and Wegovy, also mimics the GLP-1 hormone, but it requires daily injections rather than weekly ones, which may be a consideration for some patients
Saxenda (Liraglutide) Liraglutide for weight loss is available but requires daily injections, which many patients find inconvenient
Subsequently, in 2017, Liu et al
Naltrexone has shown effectiveness in preventing relapse after detoxification but may not alleviate withdrawal symptoms
However, post-marketing surveillance and patient reports have documented some individuals experiencing anxiety symptoms or panic-like episodes whilst taking GLP-1 receptor agonists
Except for five cases with unknown dosages, semaglutide doses ranged from 0.25 to 2.0 mg per week, with 0.5 mg weekly being the most common